UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000031626 |
|---|---|
| Receipt number | R000036106 |
| Scientific Title | Phase II study of surgery after S-1 + oxaliplatin + bevacizumab therapy for unresectable rectal cancer by organ-preserved TME |
| Date of disclosure of the study information | 2018/03/08 |
| Last modified on | 2023/09/15 17:13:41 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/03/07 16:30:43 | ||
| 2 | Update | 2019/09/07 09:47:53 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address TEL Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 3 | Update | 2019/09/08 16:31:37 | Date of IRB Last follow-up date |
|
| 4 | Update | 2023/03/14 17:28:15 | Recruitment status |
|
| 5 | Update | 2023/09/14 19:47:15 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 6 | Update | 2023/09/15 17:06:05 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 7 | Update | 2023/09/15 17:13:41 | Publication of results Number of participants that the trial has enrolled |
